Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
145.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (2.847%)
Market Cap: £113.79m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement-COVID-19 & Preliminary Statement

23 Mar 2020 17:47

RNS Number : 2844H
Xaar PLC
23 March 2020
 

Xaar plc

 

Trading update and revised date for full year results 

 

Xaar plc ("Xaar" or the "Group"), the leading inkjet printing technology Group, announces a confirmation of previous guidance and a revised date for the presentation of full year results.

 

Full year results

 

Preliminary financial statements for the 12 months ended 31 December 2019 were scheduled to be released 24 March 2020.

 

The FCA has strongly requested all listed companies observe a moratorium on the publication of preliminary financial statements for at least two weeks.

 

In compliance with this request, Xaar will not be releasing preliminary financial statements, but will publish full audited financial statements within four months of the financial year end, subject to any further guidance from the FCA.

 

Trading update

 

Xaar continues to make good progress with its strategy and re-iterates the preliminary guidance for 2019:

 

The Group expects to report revenues for its continuing operations of £49.4 million for the year ended 31 December 2019.

 

Group cash balances (including cash held for investment in Xaar 3D) were £25.3 million at 31 December 2019.

 

COVID19 - Update

 

The health, safety and security of our employees is our upmost priority and appropriate actions have been taken to our operational procedures to mitigate risk.

 

The Group's trading performance in 2020 to date has been in line with expectations. No orders have been cancelled, however we are mindful of the rapidly changing environment in which the business is operating.

 

While the full implications of COVID-19 on the financial performance for the current financial year are difficult to determine at this stage, the Board remains confident in the long-term prospects of the Group.

 

 

Enquiries:

Xaar plc

+44 (0)1223 423 663 

John Mills, Chief Executive Officer

Ian Tichias, Chief Finance Officer

 

 

Tulchan Communications

+44 (0)20 7353 4200

James Macey White

Giles Kernick

Hollie Ralston

 

About XaarXaar is a world leader in the development of digital inkjet technology. Our technology drives the conversion of analogue printing and manufacturing methods to digital inkjet which is more efficient, more economical and more productive than the traditional methods which have been in use for years. We design and manufacture printheads as well as systems for product decoration and industrial 3D Printing which use our inkjet technology. We are the only truly independent inkjet technology company with over 25 years of know how. We offer unrivalled inkjet expertise including technology and printhead design and development and manufacture highly customised product decoration systems and industrial 3D Printing for volume manufacturing. Our unique technologies and products are the leading enabler for innovation and for driving supply chain efficiencies for many industries. Information about Xaar is at www.xaar.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPPUQCWUPUGMW
Date   Source Headline
3rd Oct 20137:00 amRNSPACKAGING PROGRESS UPDATE
1st Oct 201311:03 amRNSTotal Voting Rights
17th Sep 20138:46 amRNSHolding(s) in Company
16th Sep 20135:56 pmRNSHolding(s) in Company
2nd Sep 201312:07 pmRNSTotal Voting Rights
30th Aug 20134:14 pmRNSHolding(s) in Company
30th Aug 20137:00 amRNSDirector/PDMR Shareholding
29th Aug 20137:00 amRNSInterim Results
2nd Aug 20139:45 amRNSTotal Voting Rights
18th Jul 20135:05 pmRNSHolding(s) in Company
17th Jul 20135:23 pmRNSHolding(s) in Company
12th Jul 201311:43 amRNSHolding(s) in Company
11th Jul 20136:12 pmRNSHolding(s) in Company
8th Jul 201312:47 pmRNSHolding(s) in Company
28th Jun 201312:46 pmRNSHolding(s) in Company
20th Jun 20139:32 amRNSHolding(s) in Company
20th Jun 20139:31 amRNSHolding(s) in Company
10th Jun 20137:00 amRNSTrading Statement
4th Jun 20137:00 amRNSTotal Voting Rights
28th May 20133:51 pmRNSHolding(s) in Company
20th May 201312:23 pmRNSHolding(s) in Company
17th May 201311:20 amRNSGrant of Options
17th May 201311:19 amRNSAGM Result
17th May 20137:00 amRNSHolding(s) in Company
16th May 20135:56 pmRNSHolding(s) in Company
10th May 201310:18 amRNSDirector/PDMR Shareholding
2nd May 20134:11 pmRNSHolding(s) in Company
2nd May 201311:43 amRNSHolding(s) in Company
1st May 20136:23 pmRNSNotice of AGM
1st May 20136:21 pmRNSAnnual Information Update
1st May 20136:19 pmRNSDirector/PDMR Shareholding
1st May 20136:18 pmRNSTotal Voting Rights
19th Apr 20133:16 pmRNSDirector/PDMR Shareholding
17th Apr 20135:31 pmRNSHolding(s) in Company
12th Apr 20134:04 pmRNSHolding(s) in Company
12th Apr 20134:03 pmRNSHolding(s) in Company
12th Apr 20139:46 amRNSDirector/PDMR Shareholding
11th Apr 20137:00 amRNSInterim Management Statement
8th Apr 201312:45 pmRNSDirector/PDMR Shareholding
4th Apr 20133:49 pmRNSHolding(s) in Company
4th Apr 20132:53 pmRNSGrant of Options
3rd Apr 201310:42 amRNSDirector/PDMR Shareholding
2nd Apr 20139:22 amRNSTotal Voting Rights
2nd Apr 20139:19 amRNSDirector/PDMR Shareholding
25th Mar 201310:59 amRNSHolding(s) in Company
19th Mar 20137:00 amRNSFinal Results
27th Feb 20139:13 amRNSXaar first with MII 450 mm silicon wafer
15th Jan 20133:55 pmRNSHolding(s) in Company
2nd Jan 20131:37 pmRNSTotal Voting Rights
12th Dec 20127:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.